| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
210 |
204 |
$14K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
31 |
30 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
57 |
57 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
47 |
46 |
$2K |
| 87529 |
|
20 |
20 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
98 |
48 |
$967.98 |
| 87511 |
|
27 |
26 |
$631.68 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
21 |
21 |
$526.40 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
21 |
21 |
$526.40 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
21 |
21 |
$500.08 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
47 |
46 |
$496.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
20 |
19 |
$447.44 |
| 87653 |
|
19 |
18 |
$421.12 |
| 87480 |
|
24 |
24 |
$360.96 |
| 81025 |
|
13 |
13 |
$77.52 |
| 81002 |
|
29 |
28 |
$67.86 |